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Abstract
Background: Patients in the last phase of their lives often use many medications. Physicians tend to lack awareness
that reviewing the usefulness of medication at the end of patients’ lives is important. The aim of this study is to
gain insight into the perspectives of patients, informal caregivers, nurses and physicians on the role of nurses in
medication management at the end of life.
Methods: Semi-structured interviews were conducted with patients in the last phase of their lives, in hospitals,
hospices and at home; and with their informal caregivers, nurses and physicians. Data were qualitatively analyzed
using the constant comparative method.
Results: Seventy-six interviews were conducted, with 17 patients, 12 informal caregivers, 15 nurses, 20 (trainee)
medical specialists and 12 family physicians. Participants agreed that the role of the nurse in medication management
includes: 1) informing, 2) supporting, 3) representing and 4) involving the patient, their informal caregivers and
physicians in medication management. Nurses have a particular role in continuity of care and proximity to the patient.
They are expected to contribute to a multidimensional assessment and approach, which is important for promoting
patients’ interest in medication management at the end of life.
Conclusions: We found that nurses can and should play an important role in medication management at the end of
life by informing, supporting, representing and involving all relevant parties. Physicians should appreciate nurses’ input
to optimize medication management in patients at the end of life. Health care professionals should recognize the role
the nurses can have in promoting patients’ interest in medication management at the end of life. Nurses should be
reinforced by education and training to take up this role.
Keywords: Nursing, Palliative care, End-of-life care, Polypharmacy, Drug therapy, Medication therapy management,
Interdisciplinary communication, Decision making, Interview
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Background
Medication management is one of the components of
palliative care that aims to improve the quality of life of
patients facing a life-limiting disease. Medication man-
agement in palliative care is challenging. Despite all re-
sources, patients’ symptom load is generally high [1–4].
The broad scope of palliative care, encompassing differ-
ent illnesses and recently diagnosed incurable disease as
well as the terminal phase, makes it even more complex.
Disadvantages of some medications may outweigh the
benefits at the end of life. Potentially inappropriate med-
ications (PIMs) are medications that should be reconsid-
ered because they have a significant risk of adverse
events, for which there is evidence for an equally or
more effective but lower-risk alternative therapy, medi-
cations that are prescribed at a higher frequency or for a
longer period than clinically indicated, or medications
with recognized drug–drug or drug–disease interactions
[5]. This applies particularly to medications prescribed
for the treatment of comorbidities or long-term preven-
tion [6–9]. In practice, timely withdrawal of potentially
inappropriate medications (PIMs) is not self-evident. As
a result, many PIMs are continued until the very end of
life [10, 11].
Physicians are primarily responsible for pharmaco-
logical treatment [12]. However, several studies show
that it is not self-evident that physicians review medica-
tion used by patients with a limited life expectancy and
that they report a variety of reasons for not considering
deprescribing of PIMs. Perhaps the most important rea-
son for not considering deprescribing is limited aware-
ness [13]. Other reasons are it is given low priority,
uncertainty about the consequences of deprescribing
medications, and avoiding confronting patients with
their impending death [13, 14]. Moreover, barriers to ad-
equate medication management exist on the level of the
organization of health care, namely the lack of
organizational support, shortage of staff, lack of time
and difficult-to-access patient medical records [15, 16].
Other barriers occur in communication and collabor-
ation between physicians and nurses [15], particularly in
the interfaces between primary, secondary and tertiary
care. Further, the nature of the relationship between
physician and nurse and the hierarchies in place may
hinder nurses from actively discussing their suggestions
regarding medication [15].
The barriers on the physicians’ side and the interdisci-
plinarity of end-of-life care, raise questions about the
role of nurses in medication management. Nurses have
an important role in palliative care and alleviation of
symptoms [17, 18]. A qualitative systematic meta-
synthesis showed nurses’ views on their role in providing
palliative care. They feel they contribute to the coordin-
ation and continuity of care and to ensuring that care is
patient-centred and adequately addresses patients’ needs
[19]. Literature about the role of nurses in medication
management in palliative care is scarce. Some studies
describe the considerable role of nurses in addressing
polypharmacy in older people at home or in long-term
care facilities [20–22]. Others highlight their role in the
administration of palliative chemotherapy [23] or admin-
istration of anticipatory medications for people who are
dying [24–26]. Wilson et al. found that there are signifi-
cant differences in the level of education of nurses, spe-
cialized nurses and nurse practitioners that could affect
their role in medication management [25]. Previous
studies about the role of nurses in palliative care or
medication management are mainly based on the per-
spective of nurses themselves [19, 23–25, 27]. We stud-
ied the perspectives of patients, informal caregivers,
nurses and physicians on the role of nurses in medica-
tion management at the end of life.
Methods
Design
This qualitative interview study is part of the MEDIcation
management in the LAST phase of life (MEDILAST) re-
search project [11, 13, 16, 28]. The purpose of the primary
study was to gain insight into the norms and values of pa-
tients, informal caregivers and health care providers re-
garding medication management at the end of life, defined
as the last 3 months of life [16]. We performed a second-
ary analysis of their perspectives on the role of nurses in
medication management at the end of life.
Participants
We asked physicians working in academic and general
hospitals (geriatrics, neurology, oncology, cardiology and
pulmonology departments), hospices and general prac-
tices, whether they cared for a patient who fulfilled the
following inclusion criteria: 1) an estimated life expect-
ancy of less than 3 months; 2) patient knew his/her life
expectancy was limited; 3) and was able to participate in
an interview. When eligible, the physician would inform
the patient about the study and ask them whether the
researchers could approach them for an interview. Only
one patient per physician was included.
Patients received written information about the study
from the researchers and were asked to sign an informed
consent form prior to the interview. Afterwards, the pa-
tient was asked for permission to ask an informal care-
giver, nurse, family physician and clinical specialist
involved in the patient’s care to participate in an inter-
view. Purposive sampling was used to ensure diversity of
patients’ age, diagnosis, social background, and religious
beliefs. All participants were requested to complete a
short questionnaire regarding their background. The
questionnaire for the nurses and physicians also
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included questions regarding their professional career,
their role in care for the patient, and their views on
medication management. In the Netherlands nurses do
not have a (de) prescriptive authority, unlike nurse spe-
cialists who formally can (de) prescribe medication. We
only included nurses in our study, no nurse specialists
[16].
Data collection
Data for this study were collected from October 2013 to
February 2015. Face to face, semi-structured interviews
were conducted by the first, second and third author,
Jimmy Arevalo (J.A.) and Roberto Perez (R.P.). The in-
terviewers included an anesthesiologist (MD), an internal
medicine resident-researcher (MD), a general practi-
tioner (MD, PhD), an anesthesiology resident-researcher
(MD) and a senior researcher in pain and palliative care
(PhD), with experience in qualitative research. We used
a topic list (see Table 1) that was developed by the pro-
ject team, guided by a review of the literature on medi-
cation management and consultation of ten specialists in
palliative care, including a nurse, physicians and phar-
macologists [29]. The topic list was refined based on
new insights during the interviews. The interviews lasted
30–60min [16].
Data analysis
The interviews were audio-recorded and transcribed ver-
batim. In contrast to the primary study in which the
transcripts were analyzed in order of collection, for this
secondary analysis we randomly analyzed transcripts per
patient case, using the constant comparative method.
This qualitative method is part of the grounded theory
approach in which concepts emerge as theory is formed
[30]. The analysis was performed with the aid of qualita-
tive research software (ATLAS.ti version 7.5.6). Two re-
searchers (first and fourth author) independently read
through the interviews and attached open codes to all is-
sues that seemed relevant to provide insight into the role
of the nurses. The analysis was performed in five rounds
of 13–15 interviews each. The coders met after each
round to discuss the evolving code list, deduce possible
themes and adjust the code book if needed. This deduct-
ive process, the interpretation of codes and discrepancies
were regularly discussed with the team members (second
author and R.P.). The final codes, themes and categories
were discussed with the whole project group.
Results
In total 76 interviews were conducted, including 17 patients
(one included patient could not be interviewed due to her
condition), 12 informal caregivers, 15 nurses, 20 (trainee)
medical specialists and 12 family physicians. Characteristics
of the participants are presented in Table 2. The nurses were
between 23 and 59 years old (mean 47.1 years), 80% were fe-
male, and they had a working experience in nursing of 3–38
years (mean 20.8 years). The majority of the nurses received
a specialty education, in palliative care [4], oncology [4], geri-
atrics [2], dialysis [1] or occupational therapy [1].
A minority of the nurses reported having discussed
discontinuation of medication with the patient. They re-
ported to be involved with: activities of daily living, ad-
ministration of medication, wound care, tube feeding,
nursing technical procedures, psychological care, social
care, care for family, information, instruction and educa-
tion, supportive conversations, kidney replacement ther-
apy, supervising blood transfusion or chemotherapy,
treatment plan monitoring, coordination of care and/or
nursing and palliative care in general.
Patients, informal caregivers, nurses and physicians
seemed to agree that nurses can act as a linchpin [19] in
medication management at the end of life. The roles of
the nurse could be categorized into roles towards the pa-
tient, towards the informal caregiver and towards the
physician (see Table 3).
Nurse-patient
Patients, informal caregivers, nurses and physicians
stated that, in medication management at the end of life,
nurses have four important roles in relation to patients:
to inform, signal, represent and support. They report
that nurses give instructions for the intake of medica-
tion, inform about the possible (side) effects of medica-
tion and about adjustments of the treatment plan.
Nurses also inform patients about how the effect of
Table 1 Topic list
General
• Thoughts and opinions about medication use
• Medication decision-making
• Preventive and chronic medication in the last phase of life
• Medication deprescription
• Communication regarding medication
• Who were involved; their responsibilities and roles
Role of the nurse
• What is your opinion about the role of the nurse in decision-making
about medication?
• In your opinion, which role can the nurse have in decision-making
about medication?
• What is your experience regarding the collaboration of your physician
and nurse relating to decision-making on the use of medication?
• Does the nurse have enough knowledge about the use of medication?
• Suppose the nurse would suggest your physician to … adjust/start/
stop … what do you think about that?
• Suppose you/the patient would be at home/in hospital/in hospice?
Who would be in charge of decision-making with respect to medica-
tion? What is the role of the nurse?
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adjustments in medication will be monitored, about dos-
age forms and the necessity of medication.
Participants also mentioned how nurses play a role in
the clinical assessment related to medication use. They
stated that nurses have a role in the assessment of the
burden of medication intake.
“Observing, reporting, … but [nurses] also monitor
the intake of medication, do the patients take them?
If they don’t take them, register this well. If they
regularly resist to take them or cannot swallow, then
I should know this and have a conversation with the
patient about this.” (Medical specialist 10)
A specific aspect that only the nurses themselves
highlighted, is the importance of a multidimensional as-
sessment and approach, taking into account physical,
psychological, social and spiritual issues.
“Interestingly, I never realized when I started work-
ing there, that the physicians don’t really know the
patient. They know he needs help with washing and
Table 3 Categories and codes regarding the role of the nurse in medication management at the end of life
Relation Category
(role)
Codes
Nurse - patient Inform Instruction intake medication, (side) effects of medication, adjustments of medication, how to monitor effect,
dosage form, explanation of necessity of medication
Signal Intake:
Problems with intake or route of administration, adherence, aversion and motivation, medication alternatives,
polypharmacy
Side effects:
Interactions, influence on quality of life, monitoring (e.g. defecation), diagnose overdose, common side effects,
effect of reduction of medication
Clinical assessment:
Clinical changes, appearance of symptoms, comfort centrally, pain perception, trigger for changes in treatment
plan, effect of medication, symptom assessment tools
Multidimensional vision:
Attention for underlying emotions of the patient, importance of medication to the patient, influence of cognitive
status, psychological wellbeing, social dimension (relations, environment), contribution to personalized
pharmacological therapy, take into account character of the patient
Represent Patient discusses wishes regarding medication with or via nurse, nurse is first contact person, nurse lends an ear
to patient, nurse expresses to physician how patient is doing, nurse receives more information from patient than
physician, attention on the patient, nurse records in file; which role patient wants to have in medication
management, motivate, put wishes and values of the patient at the centre, explore aversion towards medication,
assist in decision-making and mourning, guard over the autonomy of the patient, support in quality of life, confi-
dential advisor
Support Activities of Daily Living: order, obtain and prepare medication
Intake: self-administration of ‘as needed’ medication, facilitate intake of medication
Feasibility: Propose change of route of administration, financial aspects, consultation of pharmacist as needed
Complementary care: Non-pharmacological supportive interventions
Nurse - informal
caregiver
Inform Instruction intake, (side) effects of medication, adjustments of plan, how to monitor effect, dosage form, necessity
of medication
Support Evaluate informal caregiver capacity, contact person for questions
Involve Involve informal caregiver in case patient cannot express wishes or complaints, link between physician and
informal caregiver, asses which role informal caregiver can have in medication management, informal caregiver
can substitute for nurse
Nurse - physician Inform Report observations regarding effects, side-effects, clinical assessment and other issues to physician
Support Give input at multidisciplinary meeting/grand round/periodical meeting, think along with physician about
inappropriate or lacking medication, control function, team decision-making in medication management, phys-
ician and nurse complement each other, final decision regarding medication by physician, no role for nurse in
decision-making
Initiative:
Proposal of adjustment of medication to physician, make medication discontinuation a subject of discussion, as
needed medication for symptom control, prevention of symptoms, advance care planning, support reduction of
medication, check for contraindications
Represent Repeat information from physician to patient
Continuity:
Daily contact with patient, more frequent and prolonged contact than with physician, periodical evaluation, good
insight into the course of the disease, 24-h availability
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his pills, but what someone did in his life or what’s
important to him, they don’t know. … Well they like
to hear the other side of the story, and say ‘interest-
ing life story’, that you actually need to know to be
able to deliver good care. You should know what is
important to someone, if he grieves about things that
happened in life. How he copes with health-related
skills, medication adherence, health-promoting be-
havior, if that never interested him … that’s his au-
tonomy.” (Nurse 14)
Moreover, nurses specifically pay attention to possible
side effects of the medications, their interactions and
their impact on quality of life.
“[The nurse] observes him and sees him more than
we do, so indeed she can monitor how much pain he
has in the night and how it goes with washing. So I
think the nurse is a good indicator to determine
whether he needs more medication.” (Informal care-
giver 10)
Participants also described the role of the nurse as be-
ing a representative for the patient. Patients discuss
wishes regarding medication with or via the nurse and
the nurse informs the physician how the patient is doing.
Nurses receive more information from patients than the
physician. They are considered the first contact person,
who lends an ear to the patient and closely watches the
patient.
Lastly, participants described how the nurses support
the patient with practical aspects concerning their care
and medication use.
“I think mainly providing information about administra-
tion, routes of administration and how someone can eas-
ily swallow. If they do or don’t administer the scheduled
medication, or if they leave it with the patient and say
‘just take it later’.” (Medical specialist 11)
Nurses themselves mentioned how they support
pharmacological care by providing and ordering medica-
tion; they propose changes of administration routes and
support the patient in self-administration of ‘as needed’
medication.
“Well, we provide information, give explanation
about medication use. Yes, we try to assist people to
find their way, especially in the use of rescue opioids
… some people find that quite difficult, so we intend
to guide them. To explain it in such a way that they
know when to take a rescue, and provide informa-
tion to try to eliminate their fear of opioid use or at
least reduce it. So mainly in providing information
and guide them in using medication.” (Nurse 2)
Some nurses reported how they intervene in care using non-
pharmacological interventions and complementary care.
“Well sometimes [manage a symptom] with medica-
tion, but sometimes with other things, with comple-
mentary care. If someone expresses nausea or shows
agitation that can be of use.” (Nurse 7)
Nurse-informal caregiver
According to all participants, nurses seem to have three
roles towards the informal caregiver: to inform, support
and involve. Firstly, participants reported a role of the
nurse in giving information to the informal caregiver.
“You can discuss this [discontinuation of medication]
with them [informal caregivers] and the nurses can
also do that. They are educated well enough to com-
municate this. And if they [informal caregivers] have
questions, we can have a conversation.” (Medical
specialist 9)
Participants reported that nurses inform the informal
caregivers especially in case of a patient with reduced
consciousness.
“Well, yes, you do involve them [informal caregivers],
mainly inform them, but actually what matters is
what the patient wants. But if the patient cannot ex-
press himself well, the family serves as spokesperson
for the patient. So you try to get clear why people do
or don’t want something.” (Nurse 7)
Secondly, participants reported that nurses support in-
formal caregivers by evaluating informal caregiver cap-
acity and assessing which role informal caregivers can
have in medication management. In some cases there
was a limited or no role for the nurse because informal
caregiver(s) substitute for the nurse.
“We agreed that the nurses would watch over the
medication, because I don’t know anything about
that. So if the nurses think medication should be
changed they contact the general practitioner.” (In-
formal caregiver 18)
Thirdly, in case the patient cannot express his/her
wishes or complaints, nurses play a role in involving the
informal caregiver and act as a link between the informal
caregiver and physician.
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“Well, his daughter-in-law was involved. But she
didn’t really interfere in the pills. Her father-in-law
could perfectly express himself, so it was not neces-
sary for her to step in at that moment. ( … ) In the
course of the admission [the patient’s consciousness
reduced and] the nursing staff or I did communicate
all medication changes with the family. I discussed
major adjustments with the daughter-in-law every
time. But about small changes, I think, as a phys-
ician I don’t necessarily need to call the family. Then
I ask the nurses: “Hey, if you happen to see the
daughter-in-law or son, just tell them … ” or “if you
meet them, we are satisfied with the situation, are
they too?”, because you want their response.” (Med-
ical specialist 10)
Nurse-physician
Concerning the relation between physicians and nurses
three topics came forward in the responses of the partic-
ipants: to inform, support and represent. Primarily,
nurses monitor the patient and inform the physician
about the clinical situation and all aspects related to
medication. Moreover, most participants stated that
nurses support and complement the physician. Several
participants reported how nurses’ informing role results
in adaptations in medication management with the aim
of better symptom control or reducing polypharmacy.
Interviewer: “Do you think the physician can also
manage the medication without the nurses?” Patient:
“Yes, but I think he should have way more contact
with the patient daily. The nurses observe medica-
tion use during the whole week, the effects, how the
patient is doing, whether I lie in bed often or not.
The physician visits his patient on Fridays with the
reports of the nurses. With this he gets down to work,
well if he should do that all himself, he can’t do
other things. ( … ) So he should be glad that there
are nurses doing this kind of work, that he can rely
on home-care.” (Patient 11)
However, the final decision and responsibility for deci-
sions regarding medication is in the hands of the
physician.
“I think that someone [the nurse] who sees the pa-
tient every hour should have some influence over
part of the decision-making, about how to proceed
with that patient. So also about medication use. I
think that in the hospital they work as a team. A
physician can’t be with the patient constantly, per-
haps he sees the patient once a day, but the nurse
can. The mandate to make decisions, should be with
the physician. Though, in consultation with [the
nurse].” (Informal caregiver 2)
Two aspects regarding the role of the nurse only came
forward in the perspective of the physicians. Some physi-
cians think that nurses have a limited role in medication
management and reduction of PIMs.
Interviewer: “And does the nurse play a role in this
all?” Physician: “In the end it’s all quite complex,
even for us physicians it’s difficult to estimate the
prognosis, what is useful or not, so I don’t think so. I
do think the nurse could discuss this with the pa-
tient, whether or not after a first conversation with
the physician. So it’s not that I don’t see a role, but
not a primary role. I think it’s not up to the nurses
to critically review the medication and talk with the
patient on their own, because I think they can’t take
stock over the situation sufficiently. You can’t de-
mand that from a nurse, I think. So additional ex-
planation in a follow-up conversation fine, that can
certainly add value, but not in the decision-making
primarily about starting or continuing medication.”
(Medical specialist 2)
In addition, we found physicians who mentioned that
the role of the nurses largely depends on their level of
education.
“It depends on who comes, because now and then
you see someone involved with lay thoughts about
medication. And that doesn’t work. But indeed, in
case of a well-educated nurse, she can play a role,
for sure. I don’t think that’s a problem at all. Often
you know this about people, for whom half a word is
enough to get clear if it works or not. But sometimes
I see in those home care report folders whole stories
about this or that, and that they completely miss the
insight into how a drug works.” (Family physician 1)
Participants expressed that nurses may represent the phys-
ician by repeating and clarifying information about medica-
tion to the patient. Patients, informal caregivers, nurses and
physicians all stressed the importance of frequent and pro-
longed contact with a health care professional for adequate
medication management, and then mainly referred to the
nurse. The participants mentioned the daily contact and 24-
h availability of nurses as the main factors promoting ad-
equate medication management.
We did not find important differences in the role of
the nurses in different settings. However, physicians of
patients in hospitals and hospices mostly underlined the
value of continuity in nursing care, where physicians of
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patients residing at home face more challenges in collab-
orating with different home care teams or organizations.
“It takes a lot of time to good keep contact. And you
should invest a lot to keep it well. Nowadays we
have contact with one home care team and that
works very well. They give feedback and see things
sharply. But to assess for each home care team who
you should contact and who not, especially if they
have ten different nurses dropping in a week. Yeah,
that’s simply undoable, I wouldn’t know how to
manage.” (Medical specialist 17)
Discussion
In this interview study we assessed the perspectives of
patients, informal caregivers, nurses and physicians on
the role of nurses in medication management in patients
in the last phase of their lives. Based on our results we
hypothesize that nurses can have a pivotal role in com-
munication and collaboration regarding medication, with
patients, informal caregivers and physicians, by inform-
ing, supporting, representing and involving the other
parties. Moreover, nurses facilitate adequate pharmaco-
logical treatment as part of their regular professional ac-
tivities and especially with their practical approach.
Sekse et al. in their systematic review stress the unique
position of the nurse in palliative care, who holds every-
thing together like a spider in a web, but did not report
any involvement of the nurse in medication management
[19]. Our findings however suggest that nurses play an
important role in symptom management and contribute
to improvement of patients’ quality of life at the end of
life. Our findings are consistent with the five main prin-
ciples of symptom management (mnemonic EEMMA):
evaluation, explanation, management, monitoring, atten-
tion to detail [18]. Specific aspects described by Reid and
McCormack could also be identified in our data, for ex-
ample: a role in evaluating the effectiveness of interven-
tions, in providing information that is vital in decision-
making, in management guided by patients’ priorities
and goals, in care provision by a cohesive team and in
paying attention to detail in their assessment [18].
Others also specifically stress the role of the nurse in be-
ing a supporter to the patient [19]. Nurses are consid-
ered to have an important role being the ‘eyes and ears’
of the physician and the ‘spokesperson’ for the patient.
Physicians may lack attention for the symptom burden
in conversations with their patients, because they have
to address many other issues. Nurses spend more time
with patients and are thus more accessible for patients
to discuss their symptoms [19]. In addition, ‘as needed’
or anticipatory medications are often essential to effect-
ively treat symptoms. As nurses are more available, they
have a leading role in the administration of anticipatory
medications at the end of life [25].
Nurses have a unique opportunity to support adequate
medication management and reduction of PIMS as they
see patients on a regular basis. They aid in identifying
potential effects of changes in the medication regimen
on symptoms over time and recognize the shift in goals
of care to a palliative approach [20, 22]. As nurses are
involved in the administration and/or intake of medica-
tion, they directly observe the potential burden of poly-
pharmacy. Nurses can observe difficulties in swallowing
medication and inform the physician about the need to
adapt the medication or route of administration.
In our study we were not able to account for the level
of involvement of the informal caregiver. We did signal
an interaction between the involvement of informal
caregivers and the nurses, and consequently an influence
on how the nurses inform, support and involve the in-
formal caregiver. For informal caregivers palliative care
at home is more complex than care in a hospice or a
hospital [31, 32]. Tjia at al. describe similar conclusions
about the relation between nurses and caregivers at
home, based on medication discussions at home visits.
They identified those in several domains: teamwork
skills, organizational skills, symptom knowledge skills,
medication knowledge skills and personhood skills.
Thereby they indicate more clearly the complexity of
medication management for informal caregivers at
home, and how nurses can support in them [31]. In the
current literature we notice the explicit role of the nurse
in this field, more than involvement of the physicians
[19, 32].
Although the final decision about medication (de) pre-
scription is considered the responsibility of the phys-
ician, most participants in our study considered
medication management a team effort of patient and/or
informal caregiver, nurse and physician. This is in line
with a study of Riker and Setter on the role of the nurse
in medication management in elderly, stating that the
physician and the nurse should cooperate to get a
complete picture of a patient [20]. The holistic, multidi-
mensional view of the nurse is described as characteris-
tic of their profession [17]. Altogether, the input of the
nurse thus supports treatment that is in the patient’s
best interest, as described elsewhere for decision-making
regarding palliative chemotherapy [23].
However, some physicians interviewed in our study
suggested that nurses have a limited or no role in medi-
cation management. In a questionnaire study on physi-
cians’ experiences and opinions on medication
discontinuation at the end of life, 34% of physicians
agreed with the statement ‘nurses’ views about the dis-
continuation of medications that are not medically ne-
cessary are very important to me’ [28]. This might
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especially hold for situations where nursing staff rapidly
turns over, where there is lack of experienced nurses
and where the quality of nurses’ assessments varies [21].
In our study some physicians mentioned that the role of
the nurse depends on their level of education. This may
range from a general nursing training at different levels
to specialist palliative care education or an advanced
nurse practitioner degree. Knowledge and experience
have previously been found to influence the role of the
nurse [25], and should be taken into account in further
studies. Our results highlight that nurses can have an
important role in determining the optimal medication
regimen to improve the quality of life of patients at the
end of life. Nurses should therefore be involved in medi-
cation management. Health care professionals should
recognize the role the nurses can have and empower
them to contribute to the best possible care for patients
at the end of life [19].
Limitations
Our study involves a secondary analysis of data from in-
terviews on medication management at the end of life;
the interviews were not specifically focused on the role
of the nurse and therefore we cannot be sure that we
achieved saturation on this topic. In our study we only
included patients at the end of life with an estimated life
expectancy of less than 3 months. Palliative care encom-
passes the care for all patients with a life-limiting illness,
regardless of the life expectancy. The clinical condition
of the patient, potential disease-oriented or symptom-
oriented treatments, and the expected course of life are
only some of the factors that could influence medication
management and the role of the nurse. Further, respon-
dents’ statements in the interviews might have been in-
fluenced by social desirability. Finally, we were not able
to account for differences by care setting or level of edu-
cation of the nurse in this study, due to the relatively
small sample size.
Conclusions
Medication management in patients with a limited life
expectancy involves a complex interplay among patient,
informal caregiver, physician and nurse involved. Pa-
tients, informal caregivers, physicians and nurses agree
that nurses can and should play a role in medication
management by informing, supporting, representing and
involving the other party. Nurses have a particular role
in continuity of care and proximity to the patient, which
makes them a valuable intermediary between physician
and patient or informal caregiver. Moreover, nurses can
contribute to a multidimensional assessment and ap-
proach, which is important to promote patients’ interest
in medication management at the end of life. Although
nurses’ level of involvement may depend on their
experience and level of education, physicians should take
advantage of their input as physicians themselves may
lack awareness of the need of reconsidering the use of
medication in patients who are at the end of life. To im-
prove the quality of life of patients at the end of life,
nurses should take their role and be reinforced to do so
by education and training.
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